mapped the multicellular tumor ecosystem in situ, revealing that ICI treatment induces TME remodeling in TNBC, where proliferating CD8+ TCF1+ T cells frequently interact with MHCII+ cells, a pattern that correlates with improved ICI efficacy.[113] Additionally, Shiao et al. The gene discussed is CD8A; the disease is neoplasm.